レポートナンバー 0000041057
2031年までの北アメリカのドライアイ製品市場予測 - 地域分析 - 製品別、剤形別、タイプ別、流通チャネル別
The Insight Partners
North America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
発刊日
2025/01/13
言語英語
体裁PDF/104ページ
レポート概要
北アメリカのドライアイ製品市場は、2023年に38億2,536万米ドルと評価され、2031年までに55億8,777万米ドルに達すると予想されています。2023年から2031年にかけて4.9%のCAGRを記録すると推定されています。
ドライアイの罹患率の上昇が北アメリカのドライアイ製品市場を牽引
ドライアイ疾患（DED）は、屈折異常と白内障に次いで、眼科を受診する最も一般的な理由の3番目にランクされています。ドライアイの有病率は、特に先進国で増加しています。ドライアイは、不快感、刺激、視覚障害につながる複数の要因によって引き起こされます。米国眼科学会が発表した記事によると、DEDは世界中で約11人に1人が罹患しており、有病率はさまざまな年齢で5％から50％に及んでいます。2022年のAlconのプレスリリースによると、この疾患は世界中で約7億1,900万人、アメリカでは約3,800万人に影響を与えています。
糖尿病性網膜症により網膜に進行性の損傷が生じると、ドライアイがさらに進行します。米国眼科学会が発表した記事によると、2030年までに世界で約1億9,100万人が糖尿病性網膜症を患うと推定されています。米国疾病予防管理センター（CDC）によると、2021年にはアメリカで約960万人（全年齢層）が糖尿病性網膜症を患っていました。したがって、糖尿病性網膜症の発生率の増加がドライアイ製品市場の成長を牽引しています。
北アメリカのドライアイ製品市場の概要
北アメリカのドライアイ製品市場は、アメリカ、カナダ、メキシコに分かれています。この地域の市場成長は、ドライアイ疾患（DED）に対する認識の高まり、高齢化人口の増加、技術の進歩、眼疾患症例の増加に起因しています。さらに、新薬の頻繁な発売によりさまざまな医薬品が容易に入手できることも、この地域のドライアイ製品市場の成長を促進する主な要因の1つです。
DEDは米アメリカでは一般的ですが、診断が不十分な疾患であり、人口の高齢化が、この疾患の有病率の急増と関係している可能性があります。米国疾病管理予防センター（CDC）によると、白内障、黄斑変性、糖尿病性網膜症、緑内障などの加齢に伴う眼疾患が、アメリカにおける失明や視力障害の主な原因となっています。その他の一般的な眼疾患には、弱視や斜視があります。ドライアイは、2030年までに279万人ものアメリカの男性に影響を与えると予想されています。したがって、ドライアイの発生率の上昇に伴い、アメリカのでは治療薬の需要が高まっています。2021年1月、Kala Pharmaceuticals Inc.は、ドライアイ症状の短期（最大2週間）治療薬としてEYSUVIS 0.25%（ロテプレドノールエタボネート点眼液）を発売しました。EYSUVISは現在、アメリカの全土の全国および地域の医薬品流通センターで入手できます。
北アメリカのドライアイ製品市場の収益と2031年までの予測（百万米ドル）
北アメリカのドライアイ製品市場のセグメンテーション
北アメリカのドライアイ製品市場は、製品、剤形、タイプ、流通チャネル、国別に分類されています。
製品に基づいて、北アメリカのドライアイ製品市場は、人工涙液、抗炎症薬、涙点プラグ、分泌促進薬、経口オメガサプリメントなどに分類されます。人工涙液セグメントは、2023年に北アメリカのドライアイ製品市場で最大のシェアを占めました。さらに、抗炎症薬セグメントは、シクロスポリン、コルチコステロイド、その他にサブカテゴリ化されています。さらに、涙点プラグセグメントは、溶解性と取り外し可能なものにサブセグメント化されています。
剤形別に見ると、北アメリカのドライアイ製品市場は、点眼薬、ジェル、カプセル、錠剤、その他に分類されます。点眼薬セグメントは、2023年に北アメリカのドライアイ製品市場で最大のシェアを占めました。
タイプ別に見ると、北アメリカのドライアイ製品市場はOTCと処方薬に分かれています。2023年には、OTCセグメントが北アメリカのドライアイ製品市場でより大きなシェアを占めました。
流通チャネルに基づいて、北アメリカのドライアイ製品市場は、小売薬局、病院薬局、オンライン薬局に分類されます。小売薬局セグメントは、2023年に北アメリカのドライアイ製品市場で最大のシェアを占めました。
国別に見ると、北アメリカのドライアイ製品市場はアメリカ、カナダ、メキシコに分かれています。2023年には、北アメリカのドライアイ製品市場シェアはアメリカが独占しました。
北アメリカのドライアイ製品市場で事業を展開している大手企業としては、参天製薬（Santen Pharmaceutical Co Ltd）、Johnson & Johnson、OASIS Medical、URSAPHARM Arzneimittel GmbH、ロート製薬（Rohto Pharmaceutical Co Ltd）、OCuSOFT Inc、Bausch Health Companies Inc、AbbVie Inc、Prestige Consumer Healthcare Inc、Farmigea SpA、およびAlcon AGなどがあります。
レポート詳細
目次
Table of Contents
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Dry Eye Products Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Dry Eye
4.1.2 Upsurge in Geriatric Population
4.2 Market Restraints
4.2.1 Side Effects of Eye Drops and Product Recalls
4.3 Market Opportunities
4.3.1 Increasing Initiatives for Eye Care Awareness
4.4 Future Trends
4.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
4.5 Impact of Drivers and Restraints:
5. Dry Eye Products Market - North America Analysis
5.1 North America Dry Eye Products Market Revenue (US$ Million), 2021-2031
6. North America Dry Eye Products Market Analysis - by Product
6.1 Overview
6.2 Artificial Tears
6.2.1 Overview
6.2.2 Artificial Tears: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Anti-Inflammatory Drugs
6.3.1 Overview
6.3.2 Anti-Inflammatory Drugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
6.4 Punctal Plugs
6.4.1 Overview
6.4.2 Punctal Plugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.4.2.1 North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
6.5 Secretagogues
6.5.1 Overview
6.5.2 Secretagogues: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.6 Oral Omega Supplements
6.6.1 Overview
6.6.2 Oral Omega Supplements: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7. North America Dry Eye Products Market Analysis - by Dosage Form
7.1 Overview
7.2 Eye Drops
7.2.1 Overview
7.2.2 Eye Drops: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Gels
7.3.1 Overview
7.3.2 Gels: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Capsules and Tablets
7.4.1 Overview
7.4.2 Capsules and Tablets: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
8. North America Dry Eye Products Market Analysis - by Type
8.1 Overview
8.2 OTC
8.2.1 Overview
8.2.2 OTC: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Prescription
8.3.1 Overview
8.3.2 Prescription: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9. North America Dry Eye Products Market Analysis - by Distribution Channel
9.1 Overview
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
10. North America Dry Eye Products Market - Country Analysis
10.1 North America: Dry Eye Products Market
10.1.1 North America: Dry Eye Products Market - Revenue and Forecast Analysis - by Country
10.1.1.1 United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 United States: Dry Eye Products Market Breakdown, by Product
10.1.1.1.1.1 United States: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.1.1.2 United States: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.1.2 United States: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.1.3 United States: Dry Eye Products Market Breakdown, by Type
10.1.1.1.4 United States: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.2 Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 Canada: Dry Eye Products Market Breakdown, by Product
10.1.1.2.3.1 Canada: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.2.3.2 Canada: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.2.4 Canada: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.2.5 Canada: Dry Eye Products Market Breakdown, by Type
10.1.1.2.6 Canada: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.3 Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 Mexico: Dry Eye Products Market Breakdown, by Product
10.1.1.3.3.1 Mexico: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.3.3.2 Mexico: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.3.4 Mexico: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.3.5 Mexico: Dry Eye Products Market Breakdown, by Type
10.1.1.3.6 Mexico: Dry Eye Products Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Dry Eye Products Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Santen Pharmaceutical Co Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 OASIS Medical
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 URSAPHARM Arzneimittel GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 OCuSOFT Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 AbbVie Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Prestige Consumer Healthcare Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Farmigea SpA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Alcon AG
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. North America Dry Eye Products Market Segmentation
Table 2. North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 3. North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 4. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 5. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 6. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 7. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 8. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 9. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 10. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 11. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 12. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 13. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 14. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 15. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 16. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 18. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 19. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 20. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 21. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 22. Recent Organic Growth Strategies in the Dry Eye Products Market
Table 23. Recent Inorganic Growth Strategies in the Dry Eye Products Market
Table 24. Glossary of Terms
List of Figures
Figure 1. North America Dry Eye Products Market Segmentation, by Country
Figure 2. North America Dry Eye Products Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Dry Eye Products Market Revenue (US$ Million), 2021-2031
Figure 5. Dry Eye Products Market Share (%) - by Product (2023 and 2031)
Figure 6. Artificial Tears: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Anti-Inflammatory Drugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Punctal Plugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Secretagogues: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Oral Omega Supplements: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. North America Dry Eye Products Market Share (%) - by Dosage Form (2023 and 2031)
Figure 13. Eye Drops: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Gels: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Capsules and Tablets: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. North America Dry Eye Products Market Share (%) - by Type (2023 and 2031)
Figure 18. OTC: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Prescription: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Dry Eye Products Market Share (%) - by Distribution Channel (2023 and 2031)
Figure 21. Retail Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Hospital Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Online Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. North America: Dry Eye Products Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. North America: Dry Eye Products Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Growth Strategies in the Dry Eye Products Market
